151 related articles for article (PubMed ID: 3485506)
21. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ME1228, a new parenteral cephalosporin.
Neu HC; Saha G; Chin NX
Antimicrob Agents Chemother; 1989 Aug; 33(8):1260-7. PubMed ID: 2802554
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Okonogi K; Kuno M; Kida M; Mitsuhashi S
Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of HRE 664, a penem antibiotic.
Chin XN; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(6):509-16. PubMed ID: 2279381
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity and susceptibility to hydrolysis of S-1006.
Neu HC; Gu JW; Fang W; Chin NX
Antimicrob Agents Chemother; 1992 Jun; 36(6):1336-41. PubMed ID: 1416835
[TBL] [Abstract][Full Text] [Related]
26. The in-vitro activity and beta-lactamase stability of carumonam.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
28. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
Knothe H; Shah PM; Eckardt O
Infection; 1991; 19(5):370-6. PubMed ID: 1800379
[TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
31. In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
Gooch WM; Daly JA
Antimicrob Agents Chemother; 1985 Aug; 28(2):343-6. PubMed ID: 3879661
[TBL] [Abstract][Full Text] [Related]
32. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
[TBL] [Abstract][Full Text] [Related]
33. In-vitro antibacterial activity of L-105, a new cephalosporin.
Hikida M; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485
[TBL] [Abstract][Full Text] [Related]
34. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Husson MO; Bryskier A; Izard D; Leclerc H
Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
[TBL] [Abstract][Full Text] [Related]
35. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
[TBL] [Abstract][Full Text] [Related]
37. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.
Toda M; Arao N; Nohara C; Susaki K; Tachibana A
Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of cefcanel versus other oral cephalosporins.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
[TBL] [Abstract][Full Text] [Related]
39. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
Chin NX; Gu JW; Fang W; Neu HC
Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
